Decoy Therapeutics Announces $3.5M Private Placement with Potential for Additional Funding
Decoy Therapeutics (NASDAQ: DCOY) announced a private placement financing of up to $21 million, including an initial $3.5 million at closing and potential additional funds tied to clinical milestones. The proceeds will be used to advance the company's lead asset into clinical trials.
Topics: biotechnology clinical trials financing PIPE